• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

    15.77 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 15.77
    Bid (Size) 6.310 (200)
    Ask (Size) 25.00 (100)
    Prev. Close 15.77
    Today's Range 15.77 - 15.77
    52wk Range 4.090 - 17.15
    Shares Outstanding 21,055,392
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Reports Mixed Q4 and Full-Year 2025 Results ↗
    Enanta Pharmaceuticals reported mixed Q4 2025 results, missing revenue but beating EPS estimates. The biotech firm highlighted strong progress in its RSV and immunology drug pipeline. 
    Via Chartmill
    News headline image
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    N/A
    N/A
    1 Month
    +13.0%
    +13.0%
    3 Month
    +52.7%
    +52.7%
    6 Month
    +99.9%
    +99.9%
    1 Year
    +182.1%
    +182.1%

    More News

    Read More
    News headline image
    Earnings Scheduled For November 17, 2025 ↗
    Via Benzinga
    News headline image
    Enanta Pharma's Earnings: A Preview ↗
    Via Benzinga
    News headline image
    This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗
    Via Benzinga
    News headline image
    Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Enanta Pharmaceuticals to Present Data for Zelicapavir and EDP-323, Two Candidates in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Ryvyl Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Enanta Pharmaceuticals Stock Rises 58% – Here’s An Important Update ↗
    Via Stocktwits
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga

    Frequently Asked Questions

    Is Enanta Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Enanta Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Enanta Pharmaceuticals, Inc. - Common Stock trade on?
    Enanta Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock is ENTA on the Nasdaq Stock Market
    What is the current price of Enanta Pharmaceuticals, Inc. - Common Stock?
    The current price of Enanta Pharmaceuticals, Inc. - Common Stock is 15.77
    When was Enanta Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Enanta Pharmaceuticals, Inc. - Common Stock was at 12/31/25 04:00 PM ET
    What is the market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock is 332.04M
    How many shares of Enanta Pharmaceuticals, Inc. - Common Stock are outstanding?
    Enanta Pharmaceuticals, Inc. - Common Stock has 332M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.